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General discussion, implications 
and conclusions
This thesis is focused on the neuropsychiatric symptoms of multiple 
sclerosis (MS), especially on poor sleep quality in patients with MS. 
Emphasis is put on physical and psychological symptoms associated with 
MS, such as pain, depression, anxiety, fatigue or bladder dysfunction, and 
how they are related to poor sleep quality in MS. The thesis also focuses 
on the often overlooked bladder, bowel and sexual dysfunction and their 
relation to sleep quality and health-related quality of life in MS patients. 
In this chapter the main ﬁndings of the thesis are ﬁrst summarized (8.1) 
and discussed (8.2). The subsequent section then refers to the strengths 
and limitations of the included studies (8.3). Finally, in the last part the 
implications for clinical practice and future research are presented (8.4).
8.1  Main findings
Research question 1 (Chapter 3) 
Are bladder, bowel and sexual dysfunction associated with the physical and 
mental dimensions of HRQoL in patients stratiﬁed by duration of MS (≤5 years 
and >5 years)? 
We found that more severe disability, as measured by the EDSS and 
bladder dysfunction, was associated with lower physical health status 
in both disease duration groups. More severe sexual dysfunction was 
associated with lower mental health status in the group of patients with 
disease duration of 5 years or less. Bladder, bowel or sexual dysfunction 
was not found to play a role in mental health status in the group of patients 
with longer disease duration.
Research question 2 (Chapter 4) 
Are there differences in the prevalence and determinants of poor sleep quality in a 
sample of MS patients with disease duration ≤5 years and >5 years? 
We found that the prevalence of poor sleep quality is signiﬁcantly higher 
in patients with longer disease duration. Both disease duration groups 
differed in factors associated with poor sleep quality. The symptoms 
related to poor sleep quality in patients with disease duration of 5 years or 
less were anxiety, mental fatigue and reduced motivation, whereas pain, 
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depression and mental fatigue were associated with reduced sleep quality 
in patients with disease duration of more than 5 years.
Research question 3 (Chapter 5) 
Do gender differences exist in factors related to poor sleep quality in patients with 
MS? 
We found that factors associated with poor sleep quality in women 
concerned depression and anxiety, whereas pain was associated with 
poor sleep quality in men. Our results supported our expectations that 
different conditions may contribute to poor sleep quality in women and 
men with MS.
Research question 4 (Chapter 6) 
What are the interrelationships between pain, depression, fatigue and poor sleep 
quality? 
Our study showed that both pain and depression have a bidirectional 
relationship with sleep quality, with more severe pain or depression 
worsening sleep quality and vice versa. Moreover, almost half of the effect 
of pain on sleep quality was mediated by depression. Depression was also 
found to be the strongest predictor of mental fatigue and a signiﬁcant 
mediator of the effect of pain on fatigue, with the role of poor sleep quality 
being much smaller.
Research question 5 (Chapter 7) 
Do depression, pain and physical fatigue mediate the association between sleep 
quality and functional disability in MS patients?
We found that the relationship between poor sleep quality and disability 
in MS patients was indirect and fully mediated by depression, pain and 
physical fatigue. Our mediation model showed that poor sleep quality in 
MS patients may worsen depressive symptoms, pain and physical fatigue, 
which in turn may be associated with greater overall disability.
8.2 Discussion of the main findings
MS is a chronic disease that leads to progressive disability over time 
(1). Several MS-related impairments in body functions, together with 
limitations in activities and restrictions in participation, form the overall 
disability of people with MS, which is the main contributor to decreasing 
HRQoL in the MS population (2). 
8.2.1  Bladder, bowel and sexual dysfunction and their relationship with 
 HRQoL 
Bladder, bowel and sexual dysfunction are common MS-related 
disabilities (3-6). Despite their high prevalence, they are often overlooked. 
101
Our study showed that all of the dysfunctions –  bladder, bowel and 
sexual – can occur even in the early stage of disease. Bladder dysfunction, 
combined with neurological disability measured by the EDSS, was found 
to be a signiﬁcant contributor to a lower perception of physical health in 
patients with shorter and longer disease duration groups (cut off point 
5 years). Our ﬁndings are in line with the results of a study performed 
by Nortvedt et al., who observed an association of bladder dysfunction 
with HRQoL independently of other clinical data in a sample of 218 MS 
patients with disease duration from 9 to 19 years (3). The importance of 
bladder dysfunction in the early stage of MS controlled for other variables 
has not yet been analysed. 
Regarding bowel dysfunction, we did not ﬁnd a signiﬁcant relation 
with perceived physical or mental health in MS patients with shorter or 
longer disease duration. We cannot compare these ﬁndings with previous 
ones, as no previous study has investigated the association of bowel 
dysfunction with HRQoL adjusted for other variables. An explanation for 
the lack of an association with HRQoL may be that bowel dysfunction 
comprises mostly concerned constipation. The majority of the patients in 
our sample (70%) marked this bowel dysfunction as being uncomfortable 
for them, but not changing their functioning. It might be that the more 
severe cases of bowel dysfunction, i.e. faecal incontinence, have a poorer 
HRQoL, but this group was rather small in our sample.
Furthermore, we explored whether sexual dysfunction in MS patients 
may explain their worse HRQoL. We found that sexual dysfunction was 
associated with low perceived mental health only in the group of the 
patients who were in the early stage of the disease. Our results might be 
explained in two ways. First by the age of patients: patients with shorter 
disease duration were signiﬁcantly younger and may have had a higher 
frequency of sexual intercourse than those older and with longer disease 
duration. Kontula and Haavio-Mannila showed in their study that older 
age was signiﬁcantly associated with less frequent sexual activity in 
a sample of 844 healthy people (7). A second explanation might be the 
adjustment to the disease in patients with a more advanced stage of 
disease (8). As increased age and a more advanced stage of the disease are 
not distinguishable, both explanations might be relevant. 
8.2.2  Sleep quality and factors associated with poor sleep quality
Poor sleep quality is a common symptom associated with MS (9). In our 
study approximately 45% of the MS patients reported having poor sleep 
quality, with the prevalence being higher in women than in men. Women 
also rated their sleep on average as poorer than men, but these gender 
differences did not reach statistical signiﬁcance. We also found that sleep 
problems can occur even during the ﬁrst ﬁve years of the disease, although 
less frequently than in patients with longer disease duration. Up to now, 
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numerous MS-related symptoms have been found to be associated with 
poor sleep quality. Adequate recognition in patients of pain, depression, 
anxiety or bladder dysfunction as the most frequent determinants of poor 
sleep in the MS population may improve the treatment strategies for these 
patients. 
Determinants of poor sleep quality: the role of disease duration and 
gender
We found that determinants of poor sleep quality vary by duration of 
MS. Anxiety was the most important symptom inﬂuencing sleep quality 
in patients with disease duration of 5 years or less, whereas pain and 
depression were the main contributors to poor sleep in patients with 
disease duration of more than 5 years. All symptoms of anxiety, depression 
or pain have been previously found to be related to poor sleep (10), but the 
role of disease duration has not yet been considered. An explanation for 
these differences by disease duration in factors related to poor sleep may 
be that shortly after diagnosis patients suffer more from anxiety and fear 
connected with the uncertainty of the disease progression and that they 
realize that their life will change (11). In contrast, patients with longer 
disease duration have already adjusted to the presence of the disease 
(12), and the role of pain and depression is more relevant regarding the 
progressive neurological impairment and overall disability (13). 
Furthermore, we found some differences regarding the factors 
inﬂuencing sleep in women and men. Anxiety and depression were the 
main symptoms contributing to poor sleep in women, whereas pain 
worsened sleep quality in men. No studies exist about the differences in 
determinants of poor sleep quality in women and men with MS. Previous 
studies conducted among the general population and among patients 
with other chronic conditions have shown that not only depression and/
or anxiety (14, 15) but also pain was a speciﬁc contributor to poor sleep 
in women (16, 17). Our observation that pain worsens sleep in men and 
not in women with MS thus seems to be inconsistent with those previous 
studies. As the prevalence of anxiety, depression and pain was almost the 
same across the gender groups, our ﬁndings cannot be explained by the 
different prevalence of pain in women and men that was found in several 
studies in the general population (16, 17). 
Thus, other factors may have played a role in the association of 
pain with poor sleep. For example, women with chronic postsurgical 
pain reported the highest pain intensity during the day, whereas men 
experienced higher intensities of pain in the evening (18). This observation 
could explain the more dominant role of pain in inﬂuencing sleep in men 
than in women. Furthermore, we used a self-reported pain scale, and 
research in this area indicates that males are less likely to self-report pain. 
When they do self-report, they often have difﬁculty explaining the extent 
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of their real pain experience (19). Thus, it can be deduced that women may 
have rated low intensity stimuli without the potential to inﬂuence sleep 
as already painful, whereas men have rated as painful only those which 
interfered with their sleep. The ﬁndings on different determinants of poor 
sleep by disease duration indicate that clinicians should apply a different 
approach when assessing poor sleep quality in patients with shorter and 
longer disease duration. Similarly, women and men with MS differ in 
factors disturbing their sleep. This observation should also be taken into 
account during the diagnostic process of poor sleep quality.
Consequences of poor sleep quality
Poor sleep quality is a debilitating symptom with several consequences. 
We found that it can worsen fatigue, pain and depression and indirectly 
inﬂuence the overall disability of patients with MS. The results of our 
pathway analysis showed that depression and pain had a bidirectional 
relationship with sleep quality, with more severe depression or pain 
worsening sleep quality and vice versa. This ﬁnding implies that both 
symptoms are not just the determinants, but also the consequences of 
poor sleep. Furthermore, we extended the existing knowledge by showing 
that pain also contributed to poor sleep quality indirectly through its 
relationship with depression. Patients who reported increased levels of 
pain had more severe depressive symptoms, which in turn worsened their 
quality of sleep. This conﬁrms the previous ﬁnding that the symptoms 
pain and depression tend to cluster (20). Care providers should pay more 
attention to search for pain in all patients with depression and vice versa.
More severe mental fatigue was found to be another consequence of 
poor sleep, which is consistent with previous research (21, 22). We found 
such a relationship in patients in both the early and advanced stage of 
disease. However, the association of poor sleep quality with fatigue was 
much weaker than previously reported (21, 23). In our pathway analysis 
the strongest predictor of mental fatigue was depression, which was also 
a signiﬁcant mediator of the effect of pain on fatigue. These conﬂicting 
results may be explained by differences across the studies in the design 
of the regression models, with models containing different variables. 
It seems that models that have been adjusted for various potentially 
confounding variables like ours yield estimates of weaker associations 
of poor sleep and fatigue. This implies that previously reported ﬁndings 
may have been partially due to uncontrolled confounding. The ﬁnding of 
a negative inﬂuence of poor sleep quality on fatigue was also conﬁrmed 
in a polysomnographic cross-sectional study by Veauthier et al (22). They 
suggested that in all MS patients suffering from fatigue, a careful history 
assessing sleep problems and, where appropriate, polysomnographic 
investigations should be done (22).
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We showed that there was no direct relationship between poor sleep 
quality and disability measured by the EDSS, but that this relationship 
was fully mediated by depression, pain and fatigue. Our study is the 
ﬁrstto evaluate this relationship from this perspective of mediation. More 
speciﬁcally, patients with MS who suffered from poor sleep were more 
depressed, had more severe pain and experienced more severe fatigue, 
which in turn might lead to greater functional disability. Previous research 
regarding this topic has presented conﬂicting results (24-26). Some studies 
conﬁrmed that problematic sleep may be directly associated with greater 
disability (24, 25), whereas others did not conﬁrm such a relationship (26). 
The latter group of studies explored the determinants of poor sleep in MS 
patients, but the model adjusted for several variables, including EDSS, 
did not show a signiﬁcant association between poor sleep and disability. 
Our ﬁndings imply that the treatment of sleep problems may have 
beneﬁcial effects beyond improving sleep. These conﬂicting results might be 
explained by the fact that authors adjusted their models for factors that 
we considered to be mediators. Further studies on this topic should be 
completed to conﬁrm our results. 
8.3  Strengths and limitations of the study
Among the strengths of this study are the relatively high response rate 
within our sample (72%) and the comprehensive method of collecting 
data on all MS patients at a clinic that covers a full catchment area. 
Furthermore, we used questionnaires that are internationally recognized, 
commonly used and carefully validated to obtain the data. All recorded 
answers were personally checked during the interview with the patient 
to avoid any confusion and to increase the validity of the answers. For 
Chapters 4-7 all patients were examined by the same neurologist, which 
prevented an interrater examination bias in determining functional 
disability measured by the EDSS. Employing SEM in the data analyses 
(Chapter 6,7) is another particular strength of our study.
Our study also has some limitations, however. All analyses on both 
samples concerned cross-sectional data, which did not allow us to explore 
the full causal relationships between the studied variables, though the 
use of SEM in Chapters 6 and 7 did somewhat support the validity of 
such inferences. Despite this, our ﬁndings should still be conﬁrmed in 
longitudinal research. Second, most of the variables were measured by 
means of self-report questionnaires. Though we fully employed well-
validated questionnaires, it would be interesting to include both self-
reported sleep disturbances and those measured by e.g. polysomnograms 
to obtain a more comprehensive assessment of sleep problems. Third, in 
the sample reported on in Chapter 3, the participating MS patients were 
signiﬁcantly younger than the non-respondents. This will have led to a 
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lower share in our sample of the oldest group with the longest disease 
duration and probably the most affected group of that age in particular. A 
consequence of this is that our results may be an underestimation of the 
impact of MS in the longer run.
Despite the relatively high prevalence of anxiety and depression 
among the study population, only 7% of patients have used antidepressants 
and/or anxiolytics, so the use of these drugs has not been taken into 
account. We also did not analyse the potential effects of other drugs 
(e.g.analgetic, antiepileptics or disease modifying treatment) on sleep 
quality or on symptoms contributing to poor sleep quality. 
8.4 Implications for clinical practise and future research
Bladder and sexual dysfunction are associated with a signiﬁcantly lower 
HRQoL score in MS patients even if they have had MS for a relatively 
short time, showing a need to pay more attention to these problems in 
routine care. Recognition, examination and proper treatment are needed 
to prevent the development of more severe dysfunction, and this also 
may lead to an improvement in HRQoL. All patients with MS who 
report bladder or sexual dysfunction should be sent for a urological or 
gynecological examination. The private nature of sexual dysfunction may 
inhibit a patient and the physician in communication about it during an 
interview. It might therefore be useful to use questionnaires as a screening 
method for the recognition of sexual problems. 
Our ﬁndings of different symptoms associated with poor sleep 
quality in the early and later stages of the disease should be taken into 
account when considering an appropriate intervention. Depression 
or pain do contribute to poor sleep in patients with shorter disease 
duration, but it seems very likely that anxiety plays a more dominant 
role. Thus, physicians should pay more attention to the potential presence 
of anxiety in all patients who complain about poor sleep quality in the 
early stage of the disease. A short-term anxiolytic treatment combined 
with psychological interventions supporting coping strategies may lead 
to a decline in both symptoms and signiﬁcantly improve quality of life in 
these patients. The same principle applies for patients with longer disease 
duration. Routine assessment of pain and depression and their speciﬁc 
treatment should be included into the management strategies of poor 
sleep quality.
A gender-differential approach should be applied when assessing 
poor sleep quality in women and men, as we found gender differences 
regarding the factors that contribute to poor sleep. The more dominant 
role of mood disorders in women than in men implies that anti-depressive 
treatment may be useful in women with poor sleep. Men with sleep 
problems can also suffer from mood disorders, but it seems that physical 
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symptoms such as pain have a more important role in disturbing their 
sleep. Thus, in men effective pain management in particular deserves 
attention. Adequate management strategies of sleep disturbances in both 
genders may also have beneﬁcial effects beyond improving sleep. They 
may reduce depressive symptoms, levels of pain and physical fatigue, 
which in turn may lessen disability.
Next, an important implication of our ﬁndings regards the fact 
that pain, depression, anxiety, poor sleep quality and fatigue are closely 
linked with each other and could be deﬁned as a symptom cluster to be 
handled as a cluster (27). If patients are complaining of at least one of 
the symptoms mentioned above, healthcare providers should pay more 
attention to the potential presence of the others. When treating patients 
with poor sleep quality, it is possible that treatment directed at all 
symptoms combined may be more effective than treating each separate 
symptom. For example, cognitive-behavioural therapy is promising 
for individuals with depression and comorbid insomnia in terms of 
alleviating both symptoms (28). Some antidepressants, such as tertiary 
amine tricyclic antidepressants, venlafaxine or duoxetine, also appear to 
be efﬁcacious in the treatment of pain (29) and could therefore be used in 
people with depression and chronic pain. Reduction of both symptoms 
may in turn improve sleep and reduce fatigue. Our ﬁndings may support 
such handling of these highly prevalent and disturbing symptoms of MS. 
Poor sleep quality is a commom symptom with multiple 
determinants in MS patients and with major consequences on patients  
quality of life. Longitudinal research allowing the exploration of the full 
causal relationships is needed to conﬁrm our ﬁndings. A few studies have 
demonstrated the effect of treating sleep on fatigue, and this shows a need 
for randomized controlled intervention studies to conﬁrm such ﬁndings. 
As we found that pain, depression, poor sleep quality and fatigue are 
closely related to each other, future research should verify if treatment 
directed at all symptoms combined is indeed more effective than treating 
each separate symptom. Despite extensive research regarding the etiology 
of poor sleep quality in MS patients, the proportion of primary sleep 
disorders caused by demyelination or axonal damage in central nervous 
system and what treatment strategies should be used in such a case 
still remain unclear. Much work needs to be done to better understand 
the interrelationships between multiple neuropsychiatric MS-related 
symptoms and to develop the best therapeutic approach. 
8.5  Conclusion
We found that bladder dysfunction has a negative impact on HRQoL 
in patients with MS irrespective of disease duration, whereas sexual 
dysfunction decreases the mental component of HRQoL in patients with 
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shorter disease duration. Moreover, we found that anxiety, depression, 
pain and fatigue are the most frequent symptoms related to poor sleep 
quality in MS patients, but that their inﬂuence on sleep quality differs 
by disease duration and by gender. Anxiety was the main contributor to 
poor sleep in patients with shorter disease duration, whereas pain and 
depression were associated with reduced sleep quality in patients with 
disease duration of more than 5 years. Regarding gender differences, 
we found that mood disorders (anxiety and depression) were the main 
symptoms contributing to poor sleep in women, whereas pain worsened 
sleep quality in men. Fatigue was found to be the frequent consequence 
of poor sleep, but we also found other possible consequences, such as 
worsening of depressive symptoms and pain severity. Finally, by means 
of these symptoms functional disability can worsen indirectly. Poor sleep 
quality is a frequent neuropsychiatric symptom of MS with multiple 
causes and consequences, which should be taken into account when 
treating patients with MS. Our ﬁndings provide major clues for improving 
the quality of life of MS patients.
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